Asked by: Jenny Riddell-Carpenter (Labour - Suffolk Coastal)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, how many job vacancies there were for (a) Foundation Year 1 doctors, (b) Foundation Year 2 doctors and (c) specialty training posts in (i) England and (ii) Suffolk NHS region at the most recent date for which data is available.
Answered by Karin Smyth - Minister of State (Department of Health and Social Care)
The Department does not hold information on the number of vacancies for Foundation Year 1, Foundation Year 2, and specialty training posts in England or in the Suffolk National Health Service region.
NHS England collects and publishes data relating to the fill rates for training places in medical specialties. These are for the entry point of the initial recruitment processes for the specific training programme, rather than a measure of total vacancies at a given point in time. Further information is available at the following link:
https://medical.hee.nhs.uk/medical-training-recruitment/medical-specialty-training/fill-rates
Asked by: Rosena Allin-Khan (Labour - Tooting)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, if he will make an assessment of the adequacy of myalgic encephalomyelitis treatment in South West London.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
We published the myalgic encephalomyelitis, also known as chronic fatigue syndrome (ME/CFS), final delivery plan on 22 July 2025. The plan focusses on boosting research, improving attitudes and education, and bettering the lives of people with this debilitating disease, including those in South West London.
The ME/CFS final delivery plan includes an action for the Department and NHS England to explore whether a specialised service should be prescribed by my Rt Hon. Friend, the Secretary of State for Health and Social Care, for people with very severe ME/CFS across England. Officials from the Department have commenced discussions with NHS England on how best to take forward this action.
NHS England has also started its work on co-designing resources for systems to improve services for mild and moderate ME/CFS, including for patients in South West London. It will meet a group of key stakeholders to progress this in the coming weeks.
To support healthcare professionals in the diagnosis and management of ME/CFS, as set out in the final delivery plan, the Department has worked with NHS England to develop an e-learning programme on ME/CFS for healthcare professionals, with the aim of supporting staff to be able to provide better care and improve patient outcomes. All three sessions of the e-learning programme, with sessions one and two having universal access, whilst the third session is only available to healthcare professionals, are now available at the following link:
https://learninghub.nhs.uk/catalogue/mecfselearning?nodeId=7288
Asked by: Rosena Allin-Khan (Labour - Tooting)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps he is taking to support people with myalgic encephalomyelitis in South West London.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
We published the myalgic encephalomyelitis, also known as chronic fatigue syndrome (ME/CFS), final delivery plan on 22 July 2025. The plan focusses on boosting research, improving attitudes and education, and bettering the lives of people with this debilitating disease, including those in South West London.
The ME/CFS final delivery plan includes an action for the Department and NHS England to explore whether a specialised service should be prescribed by my Rt Hon. Friend, the Secretary of State for Health and Social Care, for people with very severe ME/CFS across England. Officials from the Department have commenced discussions with NHS England on how best to take forward this action.
NHS England has also started its work on co-designing resources for systems to improve services for mild and moderate ME/CFS, including for patients in South West London. It will meet a group of key stakeholders to progress this in the coming weeks.
To support healthcare professionals in the diagnosis and management of ME/CFS, as set out in the final delivery plan, the Department has worked with NHS England to develop an e-learning programme on ME/CFS for healthcare professionals, with the aim of supporting staff to be able to provide better care and improve patient outcomes. All three sessions of the e-learning programme, with sessions one and two having universal access, whilst the third session is only available to healthcare professionals, are now available at the following link:
https://learninghub.nhs.uk/catalogue/mecfselearning?nodeId=7288
Asked by: Edward Morello (Liberal Democrat - West Dorset)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, if he will extend eligibility for free Covid vaccines to people with heart conditions in West Dorset.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
The Government is committed to protecting those most vulnerable to COVID-19 through vaccination, as guided by the independent Joint Committee on Vaccination and Immunisation (JCVI). The primary aim of the national COVID-19 vaccination programme remains the prevention of serious illness, resulting in hospitalisations and deaths, arising from COVID-19.
The JCVI has advised that population immunity to COVID-19 has been increasing due to a combination of naturally acquired immunity following recovery from infection and vaccine-derived immunity. COVID-19 is now a relatively mild disease for most people, though it can still be unpleasant, with rates of hospitalisation and death from COVID-19 having reduced significantly since COVID-19 first emerged.
The focus of the JCVI advised programme has therefore moved towards targeted vaccination of the two groups who continue to be at higher risk of serious disease, including mortality. These are the oldest adults and individuals who are immunosuppressed. The Government has accepted the JCVI’s advice for autumn 2025 and in line with the advice, a COVID-19 vaccination is being offered to the following groups:
- adults aged 75 years old and over;
- residents in care homes for older adults; and
- individuals aged six months and over who are immunosuppressed.
As for all vaccines, the JCVI keeps the evidence under regular review.
Asked by: Edward Morello (Liberal Democrat - West Dorset)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, if he will extend eligibility for free Covid vaccines to people with lung conditions.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
The Government is committed to protecting those most vulnerable to COVID-19 through vaccination, as guided by the independent Joint Committee on Vaccination and Immunisation (JCVI). The primary aim of the national COVID-19 vaccination programme remains the prevention of serious illness, resulting in hospitalisations and deaths, arising from COVID-19.
The JCVI has advised that population immunity to COVID-19 has been increasing due to a combination of naturally acquired immunity following recovery from infection and vaccine-derived immunity. COVID-19 is now a relatively mild disease for most people, though it can still be unpleasant, with rates of hospitalisation and death from COVID-19 having reduced significantly since COVID-19 first emerged.
The focus of the JCVI advised programme has therefore moved towards targeted vaccination of the two groups who continue to be at higher risk of serious disease, including mortality. These are the oldest adults and individuals who are immunosuppressed. The Government has accepted the JCVI’s advice for autumn 2025 and in line with the advice, a COVID-19 vaccination is being offered to the following groups:
- adults aged 75 years old and over;
- residents in care homes for older adults; and
- individuals aged six months and over who are immunosuppressed.
As for all vaccines, the JCVI keeps the evidence under regular review.
Asked by: Paul Holmes (Conservative - Hamble Valley)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, whether the UK National Screening Committee plans to fast track the implementation of an in-service evaluation for newborn screening for spinal muscular atrophy.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
Progress is being made in planning and developing work to shape an in-service evaluation (ISE) of newborn blood spot screening for spinal muscular atrophy (SMA).
This follows a recommendation made in 2023 by the UK National Screening Committee which advises ministers on all aspects of population and targeted screening for an ISE in National Health Services. An ISE is needed to answer several outstanding questions related to the implementation of a newborn screening programme for SMA.
Planning for the ISE is a partnership between the Department, NHS England, the National Institute for Health and Care Research (NIHR), and other stakeholders.
Earlier in the year, the NIHR published their Health Technology Assessment research brief to appoint researchers for this work. Applications closed at the end of September 2025, and final funding decisions are expected in spring 2026. A decision on the shape and roll out of the ISE will be made after the research call process has concluded.
Asked by: Edward Morello (Liberal Democrat - West Dorset)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, if he will extent the eligibility for free Covid vaccines to people with other medical conditions in West Dorset.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
The Government is committed to protecting those most vulnerable to COVID-19 through vaccination, as guided by the independent Joint Committee on Vaccination and Immunisation (JCVI). The primary aim of the national COVID-19 vaccination programme remains the prevention of serious illness, resulting in hospitalisations and deaths, arising from COVID-19.
The JCVI has advised that population immunity to COVID-19 has been increasing due to a combination of naturally acquired immunity following recovery from infection and vaccine-derived immunity. COVID-19 is now a relatively mild disease for most people, though it can still be unpleasant, with rates of hospitalisation and death from COVID-19 having reduced significantly since COVID-19 first emerged.
The focus of the JCVI advised programme has therefore moved towards targeted vaccination of the two groups who continue to be at higher risk of serious disease, including mortality. These are the oldest adults and individuals who are immunosuppressed. The Government has accepted the JCVI’s advice for autumn 2025 and in line with the advice, a COVID-19 vaccination is being offered to the following groups:
- adults aged 75 years old and over;
- residents in care homes for older adults; and
- individuals aged six months and over who are immunosuppressed.
As for all vaccines, the JCVI keeps the evidence under regular review.
Asked by: Justin Madders (Labour - Ellesmere Port and Bromborough)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps he is taking to reduce deaths from cardiovascular disease.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
The Government is committed to reducing premature mortality from heart disease and stroke by 25% in the next 10 years. To accelerate progress towards this ambition, we will publish a Modern Service Framework for Cardiovascular Disease (CVD) in 2026, which will identify the best evidenced interventions, and drive innovation in prevention, treatment, and care. The Department and NHS England are working closely to deliver the CVD modern service framework and will engage widely throughout its development.
Alongside this, the NHS Health Check, a core component of England’s CVD prevention programme which aims to detect those at risk of heart disease and stroke aged between 40 and 74 years old, engages over 1.4 million people and through behavioural and clinical interventions, prevents approximately 500 heart attacks and strokes a year. To improve access with the programme, we are piloting an NHS Health Check online service so that people can undertake a check at a time and place that is convenient to them.
We have invested in hypertension case-finding for those over 40 years old in community pharmacies, and nearly 4.2 million people have received a free blood pressure check through the service since October 2021.
Asked by: Edward Morello (Liberal Democrat - West Dorset)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, if he will take steps to ensure stroke patients receive individualised post-discharge care.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
As set out in the 10-Year Health Plan, we are committed to improving services for patients locally by increasing the provision of services outside of a hospital setting that are delivered closer to home in the community.
The National Stroke Service Model provides best practice for stroke care, including post-discharge, which should include comprehensive rehabilitation and personalised care and support.
The National Stroke Quality Improvement in Rehabilitation programme is helping to transform community-based care by increasing access to specialist stroke rehabilitation at home.
Asked by: Edward Morello (Liberal Democrat - West Dorset)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what assessment he has made of the need for personalised care plans for stroke patients.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
As set out in the 10-Year Health Plan, we are committed to improving services for patients locally by increasing the provision of services outside of a hospital setting that are delivered closer to home in the community.
The National Stroke Service Model provides best practice for stroke care, including post-discharge, which should include comprehensive rehabilitation and personalised care and support.
The National Stroke Quality Improvement in Rehabilitation programme is helping to transform community-based care by increasing access to specialist stroke rehabilitation at home.